-
Je něco špatně v tomto záznamu ?
Clinical evaluation of a small implantable cardiac monitor with a long sensing vector
C. Piorkowski, M. Busch, G. Nölker, J. Schmitt, FX. Roithinger, G. Young, M. Táborský, G. Herrmann, D. Schmitz,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu hodnotící studie, časopisecké články, multicentrická studie
NLK
CINAHL Plus with Full Text (EBSCOhost)
od 1978-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 1978-01-01 do Před 1 rokem
PubMed
31119745
DOI
10.1111/pace.13728
Knihovny.cz E-zdroje
- MeSH
- design vybavení MeSH
- elektrokardiografie ambulantní přístrojové vybavení MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- srdeční arytmie diagnóza MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- multicentrická studie MeSH
INTRODUCTION: We conducted this study to show the safety and efficacy of a new implantable cardiac monitor (ICM), the BioMonitor 2 (Biotronik SE & Co. KG; Berlin, Germany), and to describe the arrhythmia detection performance. METHODS: The BioMonitor 2 has an extended sensing vector and is implanted close to the heart. It can transmit up to six subcutaneous electrocardiogram strips by Home Monitoring each day. We enrolled 92 patients with a standard device indication for an ICM in a single-arm, multicenter prospective trial. Patients were followed for 3 months, and 48-h Holter recordings were used to evaluate the arrhythmia detection performance. RESULTS: One patient withdrew consent and in one patient, the implantation failed. Two study device-related serious adverse events were reported, satisfying the primary safety hypothesis. Implantations took 7.4 ± 4.4 min from skin cut to suture. At 1 week, the R-wave amplitude was 0.75 ± 0.53 mV. In the 82 patients with completed Holter recordings, all patients with arrhythmias were correctly identified. False positive detections of arrhythmia were mostly irregular rhythms wrongly detected as atrial fibrillation (episode-based positive predictive value 72.5%). Daily Home Monitoring transmission was 94.9% successful. CONCLUSION: Safety and efficacy of the new device has been demonstrated. The detected R-wave amplitudes are large, leading to a low level of inappropriate detections due to over- or undersensing.
Center of Clinical Research Biotronik SE and Co KG Berlin Germany
Clinic for Cardiology and Angiology St Elisabeth Hospital Essen Essen Germany
Clinic for Cardiology Herz und Diabeteszentrum NRW Ruhr Universität Bochum Bad Oeynhausen Germany
Department of Cardiology St Andrew's Hospital Adelaide South Australia Australia
Department of Cardiology University Hospital Giessen Giessen Germany
Department of Inner Medicine Landesklinikum Mödling Mödling Austria
Department of Internal Medicine B Greifswald University Hospital Greifswald Germany
Department of Internal Medicine Cardiology University Hospital Olomouc Olomouc Czech Republic
Department of Invasive Electrophysiology Heart Center Dresden Dresden Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025810
- 003
- CZ-PrNML
- 005
- 20201222155439.0
- 007
- ta
- 008
- 201125s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/pace.13728 $2 doi
- 035 __
- $a (PubMed)31119745
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Piorkowski, Christopher $u Department of Invasive Electrophysiology, Heart Center Dresden, Dresden, Germany.
- 245 10
- $a Clinical evaluation of a small implantable cardiac monitor with a long sensing vector / $c C. Piorkowski, M. Busch, G. Nölker, J. Schmitt, FX. Roithinger, G. Young, M. Táborský, G. Herrmann, D. Schmitz,
- 520 9_
- $a INTRODUCTION: We conducted this study to show the safety and efficacy of a new implantable cardiac monitor (ICM), the BioMonitor 2 (Biotronik SE & Co. KG; Berlin, Germany), and to describe the arrhythmia detection performance. METHODS: The BioMonitor 2 has an extended sensing vector and is implanted close to the heart. It can transmit up to six subcutaneous electrocardiogram strips by Home Monitoring each day. We enrolled 92 patients with a standard device indication for an ICM in a single-arm, multicenter prospective trial. Patients were followed for 3 months, and 48-h Holter recordings were used to evaluate the arrhythmia detection performance. RESULTS: One patient withdrew consent and in one patient, the implantation failed. Two study device-related serious adverse events were reported, satisfying the primary safety hypothesis. Implantations took 7.4 ± 4.4 min from skin cut to suture. At 1 week, the R-wave amplitude was 0.75 ± 0.53 mV. In the 82 patients with completed Holter recordings, all patients with arrhythmias were correctly identified. False positive detections of arrhythmia were mostly irregular rhythms wrongly detected as atrial fibrillation (episode-based positive predictive value 72.5%). Daily Home Monitoring transmission was 94.9% successful. CONCLUSION: Safety and efficacy of the new device has been demonstrated. The detected R-wave amplitudes are large, leading to a low level of inappropriate detections due to over- or undersensing.
- 650 _2
- $a srdeční arytmie $x diagnóza $7 D001145
- 650 _2
- $a elektrokardiografie ambulantní $x přístrojové vybavení $7 D015716
- 650 _2
- $a design vybavení $7 D004867
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a hodnotící studie $7 D023362
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Busch, Mathias $u Department of Internal Medicine B, Greifswald University Hospital, Greifswald, Germany.
- 700 1_
- $a Nölker, Georg $u Clinic for Cardiology, Herz- und Diabeteszentrum NRW, Ruhr-Universität Bochum, Bad Oeynhausen, Germany.
- 700 1_
- $a Schmitt, Jörn $u Department of Cardiology, University Hospital Giessen, Giessen, Germany.
- 700 1_
- $a Roithinger, Franz Xaver $u Department of Inner Medicine, Landesklinikum Mödling, Mödling, Austria.
- 700 1_
- $a Young, Glenn $u Department of Cardiology, St. Andrew's Hospital, Adelaide, South Australia, Australia.
- 700 1_
- $a Táborský, Miloš $u Department of Internal Medicine-Cardiology, University Hospital Olomouc, Olomouc, Czech Republic.
- 700 1_
- $a Herrmann, Gundula $u Center of Clinical Research, Biotronik SE & Co. KG, Berlin, Germany.
- 700 1_
- $a Schmitz, Dietmar $u Clinic for Cardiology and Angiology, St. Elisabeth Hospital Essen, Essen, Germany.
- 773 0_
- $w MED00003671 $t Pacing and clinical electrophysiology : PACE $x 1540-8159 $g Roč. 42, č. 7 (2019), s. 1038-1046
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31119745 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222155435 $b ABA008
- 999 __
- $a ok $b bmc $g 1599955 $s 1116496
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 42 $c 7 $d 1038-1046 $e 20190605 $i 1540-8159 $m Pacing and clinical electrophysiology $n Pacing Clin Electrophysiol $x MED00003671
- LZP __
- $a Pubmed-20201125